Saturday, 17 October 2026European Markets

EBUSCO HOLDING Stock Is 27% Down In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of EBUSCO HOLDING (AEX-Index: EBUS.AS) slid by a staggering 27.12% in 21 sessions from €12.61 to €9.19 at 14:10 EST on Friday, after two consecutive sessions in a row of gains. AEX-Index is jumping 0.54% to €759.84, following the last session's upward trend.

EBUSCO HOLDING's last close was €9.19, 63.68% below its 52-week high of €25.30.

About EBUSCO HOLDING

Ebusco Holding N.V., together with its subsidiaries, develops, manufactures, and distributes zero emission buses, batteries, and charging systems in the Netherlands, Belgium, France, Germany, Norway, Switzerland, and Denmark. It also sells ancillary items and services; and provides electric vehicle ecosystem repair and maintenance services. The company was founded in 2010 and is headquartered in Deurne, the Netherlands.

Earnings Per Share

As for profitability, EBUSCO HOLDING has a trailing twelve months EPS of €322.07.

PE Ratio

EBUSCO HOLDING has a trailing twelve months price to earnings ratio of 0.03. Meaning, the purchaser of the share is investing €0.03 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -11.15%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 290.3%, now sitting on 111.62M for the twelve trailing months.

Volume

Today's last reported volume for EBUSCO HOLDING is 98197 which is 38.08% below its average volume of 158607.

Yearly Top and Bottom Value

EBUSCO HOLDING's stock is valued at €9.19 at 14:10 EST, way under its 52-week high of €25.30 and above its 52-week low of €9.16.

More news about EBUSCO HOLDING (EBUS.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com